Marshall Wace’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-700
Closed -$327K 3415
2025
Q4
$327K Buy
+700
New +$325K ﹤0.01% 2418
2024
Q1
Sell
-3,500
Closed -$947K 2589
2023
Q4
$947K Buy
+3,500
New +$865K ﹤0.01% 1495

Other funds holding HCA

Marshall Wace's HCA Position: Q1 2026 in Review

Marshall Wace reduced its HCA Healthcare (HCA) stake by 30% in Q1 2026, selling an estimated $9.56M and leaving 44,059 shares worth $20.9M. The position accounts for 0.02% of the portfolio, ranked #691.

Marshall Wace first reported a position in HCA in Q2 2014 and has held it in 28 quarters since. The position peaked at $52M in Q4 2019. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Marshall Wace held 44,059 shares of HCA Healthcare worth $20.9M as of Q1 2026.
  • Marshall Wace sold 18,983 HCA Healthcare shares in Q1 2026, an estimated $9.56M.
  • HCA Healthcare made up 0.02% of Marshall Wace's portfolio in Q1 2026, its #691 holding.
  • Marshall Wace first reported a position in HCA Healthcare in Q2 2014 and has held it in 28 quarters since.
  • Marshall Wace's HCA Healthcare position peaked at $52M in Q4 2019.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.